NR 507 Week 1-3 Edapt; Questions and Materials
Document Preview
Unlock Full 70 Page Document Instantly.
Document Overview
EDapt Module Questions NR507 Edapts Week 1 Hives (Urticaria) - Type 1 Allergic Reaction – dermal/skin manifestation. Allergic Contact Dermatitis – Type 4 Allergic Reaction - an example of a Type IV hypersensitivity reaction mediated by T-cells. When the individual comes in contact with the antigen (e.g. poison ivy), an antigen complex is formed. On subsequent exposure to the antigen, sensitized T-cells activate the inflammatory process that causes the allergic contact dermatitis to appear. Type 2 (Cytotoxic/tissue-specific) hypersensitivity reactions are mediated by: IgG or IgM. Which of the following are considered the “first responders” of the innate immune system? Neutrophils appear first in any immune response. Anaphylaxis is a Type 1 Allergic Reaction - Type 1 hypersensitivity reactions are mediated by IgE and mast cells. An individual who is highly sensitized to the antigen may experience anaphylaxis. Damage occurs with ABO incompatibility because: Complement damages RBC membrane causing cell lysis. Damage from ABO incompatibility occurs because of the effects of complement on the RBC membrane that results in RBC lysis. The diagnosis for an individual who presents to the office with sudden swollen lips and eyes, shortness of breath and throat tightness after a bee sting is: anaphylaxis. The symptoms are consistent with the life-threating condition, anaphylaxis after being exposed. to a bee sting. Which of the following assessment findings would be expected in a patient who presents with urticaria? Eosinophilia. Eosinophils are present in the allergic reaction. Type IV cytotoxic hypersensitivity reactions are mediated by: T-cells. Types of Hypersensitivity Reactions Type Mechanism Example Pathology I. IgE action on mast cells Hay fever Mast cell degranulation results in an inflammatory response II. Tissue-specific destruction or impairment because of: Antibody binding followed by lysis via complement Antibody binding followed by macrophage phagocytosis Antibody binding followed by neutrophil destruction Antibody- dependent cell (NK)-mediated cytotoxicity, or Antireceptor antibodies 1-ABO incompatibility 5-Graves' disease 1-Complement damages RBC membrane and cells lyse 5-Autoantibodies specific for thyroid tissue impair receptor for TSH III. Antigen-Antibody complex deposited in tissues Raynaud’s phenomenon Complex deposited in small peripheral vessels in cool temperatures leading to vasoconstriction and blocked circulation IV. Cytotoxic T cell- mediated Contact dermatitis (e.g., poison ivy) T cells attack tissue directly (no antibody) Edapt Slides Type I: Allergic Reaction On initial encounter with an allergen, the individual will first produce IgE antibodies. Afte r the allergen is cleared, the remaining IgE molecules will be bound by mast cells, baso phils, and eosinophils that contain receptors for the IgE molecules. This process is refer red to as sensitization. On subsequent exposure to the allergen, the IgE molecules locat ed on the sensitized cells induces their immediate degranulation. This causes the releas e of inflammatory mediators such as histamine, leukotrienes, and prostaglandins that re sults in vasodilation, bronchial smooth muscle contraction, and mucus production. Type I hypersensitivity reactions can be local or systemic. Systemic reactions can result in an aphylaxis, a potentially life threatening condition. Allergic asthma is an example of a Type I hypersensitivity reactio n. On exposure to
Full content available after purchase or with an active subscription.
Related Products
Related Products
NR 507 Week 1 Assignment; Immune Response
NR 507 Week 1 Discussion; Allergies and Immunocompromised States
NR 507 Week 1 Discussion; Human Immunodeficiency Virus (HIV)
NR 507 Week 1 Discussion; Immune System Dysfunction & Rash Analysis
NR 507 Week 1 Discussion; Immunity; Hypersensitivity-Immunodeficiency
NR 507 Week 1 Discussion; Introductions (not graded, but required)
NR 507 Week 1 Discussion; Introductions (not graded, but required) & Summary
NR 507 Week 1 Discussion; Pathophysiology and Clinical Aspects of HIV
NR 507 Week 1 Edapt Practice Questions; Hypersensitivity, anemias, immunodeficiency.
NR 507 Week 1 Edapt; Anemias & hemoglobinopathies
NR 507 Week 1 Edapt; Hypersensitivity
NR 507 Week 1 Edapt; Introduction to Anemia
NR 507 Week 2 Assignment; Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological and Cardiovascular Disorders
NR 507 Week 2 Assignment; Hematological Disorders
NR 507 Week 2 Clinical Reasoning Webinar Transcript
NR 507 Week 2 Discussion; Amyotrophic Lateral Sclerosis (ALS)
NR 507 Week 2 Discussion; Choose Your Own Pathophysiology Adventure, Part 1 of 3
NR 507 Week 2 Discussion; Chronic Obstructive Pulmonary Disease
NR 507 Week 2 Edapt Practice Questions; Cardiovascular and Hematology Disorders
NR 507 Week 2 Edapt; Cardio & Hematologic Components; Key Points & Final Review
NR 507 Week 2 Edapt; Cardiovascular and hematology disorders - Practice Questions-Answers
NR 507 Week 2 Edapt; Cardiovascular Disorders
NR 507 Week 2 Edapt; Hematology
NR 507 Week 2 Edapt; Study Guide Anemia
NR 507 Week 3 Assignment; Alterations in Pulmonary Function
NR 507 Week 3 Assignment; Alterations in Pulmonary Function.
NR 507 Week 3 Discussion
NR 507 Week 3 Discussion; Anemia and Its Implications
NR 507 Week 3 Discussion; Heart failure (HF)
NR 507 Week 3 Discussion; Pathophysiology of Anemia and Asthma
NR 507 Week 3 Edapt Practice Questions; Respiratory System
NR 507 Week 3 Edapt; Obstructive and Restrictive Lung Diseases
NR 507 Week 3 Edapt; Respiratory System - Practice Questions-Answers
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders
NR 507 Week 4 Assignment; Urinary System Pathologies; Common Diseases and Disorders.
NR 507 Week 4 Collaboration Cafe; Cardiovascular Involvement in SLE Pathophysiology
NR 507 Week 4 Collaboration Cafe; Urinary System Pathologies
NR 507 Week 4 Edapt Practice Questions; Urinary, Renal System
NR 507 Week 4 Edapt; Urinary System Pathologies
NR 507 Week 4 Midterm Exam Practice Questions-Answers
NR 507 Week 4 Midterm Exam Solved
NR 507 Week 4 Midterm Exam..
NR 507 Week 4 Midterm Practice Exam Questions (Weeks 1-4)
NR 507 Week 4 Midterm Real Past Exam Questions-Answers
NR 507 Week 4-5 Edapt Questions and Material
NR 507 Week 5 Assignment; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3
NR 507 Week 5 Discussion; Choose Your Own Pathophysiology Adventure Part 2 of 3 - Sickle Cell Disease
NR 507 Week 5 Discussion; COPD and Its Implications
NR 507 Week 5 Edapt; Anxiety Disorders
NR 507 Week 5 Edapt; Depression
NR 507 Week 5 Edapt; GERD; Alterations in the Gastrointestinal System
NR 507 Week 5 Edapt; Inflammatory Bowel Disease
NR 507 Week 5 Edapt; Liver Cirrhosis
NR 507 Week 5 Edapt; Mood Disorders
NR 507 Week 5 Edapt; Obstructive Gastrointestinal Disorders
NR 507 Week 5 Edapt; Peptic Ulcer Disease
NR 507 Week 5 Edapt; Schizophrenia, Ch 19, Pg 618
NR 507 Week 5-6 Edapt Content
NR 507 Week 6 Assignment; Alterations in the Endocrine System
NR 507 Week 6 Case Study; Pathophysiology & Clinical Findings of Type 2 Diabetes
NR 507 Week 6 Discussion
NR 507 Week 6 Discussion; Cirrhosis
NR 507 Week 7 Assignment; CNS; Sensory and Motor Disorders
NR 507 Week 7 CNS; Sensory and Motor Disorders
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3
NR 507 Week 7 Discussion; Choose Your Own Pathophysiology Adventure Part 3 of 3 - Heart Failure and Neuropathy
NR 507 Week 7 Edapt Content; CNS Sensory and Motor Disorders
NR 507 Week 8 CNS; Brain Disorders & Dermatological Conditions
NR 507 Week 8 Collaboration Cafe
NR 507 Week 8 Collaborative Cafe
NR 507 Week 8 Edapt Content; CNS Brain Disorders
NR 507 Week 8 Final Exam - Questions-Answers
NR 507 Week 8 Final Exam Compilation
NR 507 Week 8 Final Exam Master Study Guide
NR 507 Week 8 Final Exam Master Study Guide - Answered Bullet-by-Bullet.
NR 507 Week 8 Final Exam Review - Made this for the final and really helped me ace it!
NR 507 Week 8 Final Exam Study Guide Review
NR 507 Week 8 Final Exam..
NR 507 Week 8 Group Final Exam Questions
NR 507NP Week 7 CNS; Sensory and Motor Disorders
NR 507NP Week 8 CNS; Brain Disorders
NR 507NP Week 8 Dermatology Conditions
Academic Use Notice: This resource is provided strictly as study support material to help students review concepts, understand topic structure, and prepare their own original academic work responsibly. It is not intended to be submitted directly as a student's own work.